Titre : Burkholderiaceae

Burkholderiaceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Government Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Burkholderiaceae : Questions médicales les plus fréquentes", "headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-16", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Burkholderiaceae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Burkholderiales", "url": "https://questionsmedicales.fr/mesh/D000073556", "about": { "@type": "MedicalCondition", "name": "Burkholderiales", "code": { "@type": "MedicalCode", "code": "D000073556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia", "alternateName": "Burkholderia", "url": "https://questionsmedicales.fr/mesh/D019117", "about": { "@type": "MedicalCondition", "name": "Burkholderia", "code": { "@type": "MedicalCode", "code": "D019117", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia cepacia complex", "alternateName": "Burkholderia cepacia complex", "url": "https://questionsmedicales.fr/mesh/D042602", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia complex", "code": { "@type": "MedicalCode", "code": "D042602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia cenocepacia", "alternateName": "Burkholderia cenocepacia", "url": "https://questionsmedicales.fr/mesh/D057508", "about": { "@type": "MedicalCondition", "name": "Burkholderia cenocepacia", "code": { "@type": "MedicalCode", "code": "D057508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.490" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia cepacia", "alternateName": "Burkholderia cepacia", "url": "https://questionsmedicales.fr/mesh/D016956", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia", "code": { "@type": "MedicalCode", "code": "D016956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Burkholderia cenocepacia", "alternateName": "Burkholderia cenocepacia", "url": "https://questionsmedicales.fr/mesh/D057508", "about": { "@type": "MedicalCondition", "name": "Burkholderia cenocepacia", "code": { "@type": "MedicalCode", "code": "D057508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.490" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia cepacia", "alternateName": "Burkholderia cepacia", "url": "https://questionsmedicales.fr/mesh/D016956", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia", "code": { "@type": "MedicalCode", "code": "D016956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.500" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia gladioli", "alternateName": "Burkholderia gladioli", "url": "https://questionsmedicales.fr/mesh/D042725", "about": { "@type": "MedicalCondition", "name": "Burkholderia gladioli", "code": { "@type": "MedicalCode", "code": "D042725", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.355" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia mallei", "alternateName": "Burkholderia mallei", "url": "https://questionsmedicales.fr/mesh/D042726", "about": { "@type": "MedicalCondition", "name": "Burkholderia mallei", "code": { "@type": "MedicalCode", "code": "D042726", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.477" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia pseudomallei", "alternateName": "Burkholderia pseudomallei", "url": "https://questionsmedicales.fr/mesh/D016957", "about": { "@type": "MedicalCondition", "name": "Burkholderia pseudomallei", "code": { "@type": "MedicalCode", "code": "D016957", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Cupriavidus", "alternateName": "Cupriavidus", "url": "https://questionsmedicales.fr/mesh/D049921", "about": { "@type": "MedicalCondition", "name": "Cupriavidus", "code": { "@type": "MedicalCode", "code": "D049921", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cupriavidus necator", "alternateName": "Cupriavidus necator", "url": "https://questionsmedicales.fr/mesh/D020118", "about": { "@type": "MedicalCondition", "name": "Cupriavidus necator", "code": { "@type": "MedicalCode", "code": "D020118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.200.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Ralstonia", "alternateName": "Ralstonia", "url": "https://questionsmedicales.fr/mesh/D043367", "about": { "@type": "MedicalCondition", "name": "Ralstonia", "code": { "@type": "MedicalCode", "code": "D043367", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ralstonia pickettii", "alternateName": "Ralstonia pickettii", "url": "https://questionsmedicales.fr/mesh/D049920", "about": { "@type": "MedicalCondition", "name": "Ralstonia pickettii", "code": { "@type": "MedicalCode", "code": "D049920", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600.600" } } }, { "@type": "MedicalWebPage", "name": "Ralstonia solanacearum", "alternateName": "Ralstonia solanacearum", "url": "https://questionsmedicales.fr/mesh/D043368", "about": { "@type": "MedicalCondition", "name": "Ralstonia solanacearum", "code": { "@type": "MedicalCode", "code": "D043368", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Burkholderiaceae", "alternateName": "Burkholderiaceae", "code": { "@type": "MedicalCode", "code": "D042521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yusuke Takashima", "url": "https://questionsmedicales.fr/author/Yusuke%20Takashima", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Yousuke Degawa", "url": "https://questionsmedicales.fr/author/Yousuke%20Degawa", "affiliation": { "@type": "Organization", "name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba." } }, { "@type": "Person", "name": "Tomoyasu Nishizawa", "url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Hiroyuki Ohta", "url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Kazuhiko Narisawa", "url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Caregiver Perspectives on Improving Government Nutrition Benefit Programs.", "datePublished": "2024-10-08", "url": "https://questionsmedicales.fr/article/39376182", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1542/peds.2024-067012" } }, { "@type": "ScholarlyArticle", "name": "Rethinking malaria: Governance lessons from other disease programs.", "datePublished": "2022-09-27", "url": "https://questionsmedicales.fr/article/36962609", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pgph.0000966" } }, { "@type": "ScholarlyArticle", "name": "Cost-benefit analysis of a non-government organization and Australian government collaborative supported employment program for autistic people.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36457180", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/13623613221138643" } }, { "@type": "ScholarlyArticle", "name": "Government-enterprise Green Collaborative Governance and Urban Carbon Emission Reduction: Empirical Evidence from Green PPP Programs.", "datePublished": "2024-06-05", "url": "https://questionsmedicales.fr/article/38849001", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envres.2024.119335" } }, { "@type": "ScholarlyArticle", "name": "A machine learning (ML) approach to understanding participation in government nutrition programs.", "datePublished": "2024-06-21", "url": "https://questionsmedicales.fr/article/38959778", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.copsyc.2024.101830" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Betaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020562" }, { "@type": "ListItem", "position": 5, "name": "Burkholderiales", "item": "https://questionsmedicales.fr/mesh/D000073556" }, { "@type": "ListItem", "position": 6, "name": "Burkholderiaceae", "item": "https://questionsmedicales.fr/mesh/D042521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Burkholderiaceae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Burkholderiaceae", "description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Government+Programs&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Burkholderiaceae", "description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Government+Programs&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Burkholderiaceae", "description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Government+Programs&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Burkholderiaceae", "description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Government+Programs&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Burkholderiaceae", "description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Government+Programs&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Burkholderiaceae", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Government+Programs&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Burkholderiaceae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Burkholderia ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas." } }, { "@type": "Question", "name": "Les tests sérologiques sont-ils utiles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia." } }, { "@type": "Question", "name": "Quelle est l'importance de l'antibiogramme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par Burkholderia ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées." } }, { "@type": "Question", "name": "Les infections pulmonaires sont-elles fréquentes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes." } }, { "@type": "Question", "name": "Burkholderia peut-elle causer des infections cutanées ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de Burkholderia ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient." } }, { "@type": "Question", "name": "Comment prévenir les infections par Burkholderia ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque." } }, { "@type": "Question", "name": "Les vaccinations sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles être surveillées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près." } }, { "@type": "Question", "name": "Les mesures d'hygiène hospitalière sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales." } }, { "@type": "Question", "name": "Les équipements de protection individuelle sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque." } }, { "@type": "Question", "name": "Quel est le traitement standard pour les infections par Burkholderia ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem." } }, { "@type": "Question", "name": "Les infections sont-elles résistantes aux antibiotiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées." } }, { "@type": "Question", "name": "Le traitement préventif est-il possible ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection." } }, { "@type": "Question", "name": "Quelle est la durée du traitement antibiotique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par Burkholderia ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès." } }, { "@type": "Question", "name": "Les infections peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles." } }, { "@type": "Question", "name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées." } }, { "@type": "Question", "name": "Quelles sont les séquelles possibles après une infection ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes." } }, { "@type": "Question", "name": "Les patients atteints de cysticfibrose sont-ils à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les travailleurs de la santé sont-ils exposés ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux." } }, { "@type": "Question", "name": "Les voyages dans certaines régions augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection." } } ] } ] }

Sources (10000 au total)

Caregiver Perspectives on Improving Government Nutrition Benefit Programs.

The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and Supplemental Nutrition Assistance Program (SNAP) provide essential nutrition support for low-income families. Howe... We conducted semistructured phone interviews with caregivers of pediatric patients who were current or former WIC and SNAP beneficiaries at 2 academic pediatric primary care clinics. Interviews were r... We interviewed 40 caregivers who were predominantly Black (88%) mothers (90%), with 53% and 83% currently using WIC and SNAP, respectively. We identified 4 themes related to participation barriers: (1... WIC and SNAP beneficiaries identified several modifiable barriers to enrollment and benefits redemption. Pediatric providers should advocate for programmatic improvements that make it easier for famil...

Cost-benefit analysis of a non-government organization and Australian government collaborative supported employment program for autistic people.

Relative to the size of the population, there are fewer autistic people than non-autistic people in the workforce. Employment programs that provide extra support to autistic people may help them to ga...

Structure, governance and delivery of specialist training programs in periodontology and implant dentistry.

To update the competences and learning outcomes and their evaluation, educational methods and education quality assurance for the training of contemporary specialists in periodontology, including the ... Evidence was gathered through scientific databases and by searching for European policies on higher education. In addition, two surveys were designed and sent to program directors and graduates.... Program directors reported that curricula were periodically adapted to incorporate advances in diagnosis, classification, treatment guidelines and clinical techniques, including the 2018 Classificatio... An update of competences and learning outcomes of specialist training in periodontology is proposed, including knowledge and practical application of the 2018 Classification and CPGs. Harmonizing spec...

Sustainable financing of AYSRH programs by local governments through the TCI model.

Despite the existence of a legal policy framework, financing of adolescent and youth sexual and reproductive health (AYSRH) services has remained weak. External donors are the main financing agents, w... The purpose of this manuscript is to assess the contribution of The Challenge Initiative (TCI) Business Unusual model on AYSRH services in the counties of Kilifi and Migori, as well as to examine the ... Migori and Kilifi Counties chose to partner with TCI to implement the Business Unusual model. Interested counties apply for the initiative's support and commit to contributing a portion of the funding... The results showed a 60% increase in financial commitments on AYSRH programming from 2018 to 2021 in both counties. The average expenditure for committed funds for Kilifi and Migori Counties was 116% ... The increase in adolescent contraceptive uptake might have been as a result of the system strengthening through self-financing of AYSRH programs, the institutionalization of HIIs, and the coaching. Lo...

Access of people with pulmonary tuberculosis to government programs: Primary Care professionals' perceptions.

to analyze Primary Health Care professionals' perceptions about the access of people with pulmonary tuberculosis to government social support and income transfer programs.... multicenter/qualitative study, carried out in Family Health Units in four Brazilian capitals: Belém/Pará, Campo Grande/Mato Grosso do Sul, Recife/Pernambuco and Rio de Janeiro/Rio de Janeiro. Fifty-ei... among the participants, 45/77.6% were women and 33/56.9% were between 25 and 40 years old. Two thematic categories were organized, demonstrating the perceptions about the possibilities of access to go... it is necessary to move forward in improving patient access to social programs....